1. Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD, Folstein SE, Haines JL, Sutcliffe JS (2004) Am J Med Genet B Neuropsychiatr Genet 127B(1): 104-12
    › Primary publication · 15108191 (PubMed)
  2. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD (2004) Proc Natl Acad Sci U S A 101(23): 8762-7
    › Primary publication · 15173594 (PubMed) · PMC423269 (PubMed Central)
  3. Dopamine transporters depolarize neurons by a channel mechanism. Carvelli L, McDonald PW, Blakely RD, DeFelice LJ (2004) Proc Natl Acad Sci U S A 101(45): 16046-51
    › Primary publication · 15520385 (PubMed) · PMC528740 (PubMed Central)
  4. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD (2004) Mol Pharmacol 65(6): 1462-74
    › Primary publication · 15155839 (PubMed)
  5. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, Spindel ER (2004) Endocrinology 145(5): 2498-506
    › Primary publication · 14764638 (PubMed)
  6. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD (2003) J Neurosci 23(30): 9697-709
    › Primary publication · 14585997 (PubMed) · PMC6740902 (PubMed Central)
  7. Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. Miner LH, Schroeter S, Blakely RD, Sesack SR (2003) J Comp Neurol 466(4): 478-94
    › Primary publication · 14566944 (PubMed)
  8. The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Nass R, Blakely RD (2003) Annu Rev Pharmacol Toxicol : 521-44
    › Primary publication · 12415122 (PubMed)
  9. Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. Henry LK, Adkins EM, Han Q, Blakely RD (2003) J Biol Chem 278(39): 37052-63
    › Primary publication · 12869570 (PubMed)
  10. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. Lakso M, Vartiainen S, Moilanen AM, Sirviö J, Thomas JH, Nass R, Blakely RD, Wong G (2003) J Neurochem 86(1): 165-72
    › Primary publication · 12807436 (PubMed)